MX2023003147A - Mezclas de polisorbato que tienen distribucion de esteres de acidos grasos modificados. - Google Patents

Mezclas de polisorbato que tienen distribucion de esteres de acidos grasos modificados.

Info

Publication number
MX2023003147A
MX2023003147A MX2023003147A MX2023003147A MX2023003147A MX 2023003147 A MX2023003147 A MX 2023003147A MX 2023003147 A MX2023003147 A MX 2023003147A MX 2023003147 A MX2023003147 A MX 2023003147A MX 2023003147 A MX2023003147 A MX 2023003147A
Authority
MX
Mexico
Prior art keywords
fatty acid
acid ester
polysorbate
mixtures
modified fatty
Prior art date
Application number
MX2023003147A
Other languages
English (en)
Inventor
Amit Srivastava
Anthony Tomlinson
Sandeep Yadav
Nidhi Doshi
Tamanna Shobha
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of MX2023003147A publication Critical patent/MX2023003147A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)

Abstract

La presente divulgación proporciona composiciones de polisorbato 20 con concentraciones particulares de ésteres de ácidos grasos. En algunas formas de realización, pueden usarse en formulaciones farmacéuticas, por ejemplo, para mejorar la estabilidad.
MX2023003147A 2020-09-24 2021-09-23 Mezclas de polisorbato que tienen distribucion de esteres de acidos grasos modificados. MX2023003147A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US202063082606P 2020-09-24 2020-09-24
US202063082611P 2020-09-24 2020-09-24
US202163168567P 2021-03-31 2021-03-31
PCT/US2021/051681 WO2022066858A1 (en) 2020-09-24 2021-09-23 Polysorbate mixtures having modified fatty acid ester distribution

Publications (1)

Publication Number Publication Date
MX2023003147A true MX2023003147A (es) 2023-03-24

Family

ID=78414738

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023003147A MX2023003147A (es) 2020-09-24 2021-09-23 Mezclas de polisorbato que tienen distribucion de esteres de acidos grasos modificados.

Country Status (11)

Country Link
US (2) US11833206B2 (es)
EP (1) EP4217003A1 (es)
JP (1) JP2023542953A (es)
KR (1) KR20230074134A (es)
AU (1) AU2021347978A1 (es)
BR (1) BR112023005431A2 (es)
CA (1) CA3193581A1 (es)
IL (1) IL301259A (es)
MX (1) MX2023003147A (es)
TW (1) TW202228781A (es)
WO (1) WO2022066858A1 (es)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5641870A (en) 1995-04-20 1997-06-24 Genentech, Inc. Low pH hydrophobic interaction chromatography for antibody purification

Also Published As

Publication number Publication date
KR20230074134A (ko) 2023-05-26
US20220111054A1 (en) 2022-04-14
US11833206B2 (en) 2023-12-05
US20240050572A1 (en) 2024-02-15
BR112023005431A2 (pt) 2023-05-09
JP2023542953A (ja) 2023-10-12
IL301259A (en) 2023-05-01
CA3193581A1 (en) 2022-03-31
TW202228781A (zh) 2022-08-01
AU2021347978A1 (en) 2023-03-16
EP4217003A1 (en) 2023-08-02
WO2022066858A1 (en) 2022-03-31

Similar Documents

Publication Publication Date Title
MY185428A (en) Self-emulsifying composition of ?-3 fatty acid
WO2014167554A3 (en) Composition and formulation of antimicrobial agents, processes thereof and methods for treating microbial infections
BR112015008186A2 (pt) formulação de um anticorpo estável e de baixa viscosidade
BR112012020666A2 (pt) "composições de óleo de ácido esteraridônico"
BR112013020167A2 (pt) melhoradores de permeação para formulações tópicas
BR0311762A (pt) Beneficiador de cetano orgânico
YU86001A (sh) Novi preparat i oblik, u kojem se daje lek, koji sadrži aktivno jedinjenje labilno prema kiselini
EP4233843A3 (en) Antibody compositions
BRPI0916936A8 (pt) Composições farmacêuticas, uso de clevidipina e método de reduzir impurezas.
RS54584B1 (en) 15-HEPE PREPARATIONS AND PROCEDURES FOR THEIR USE
ATE413865T1 (de) Zusammensetzungen mit alphahydroxy-säureester zur wirkstofffreisetzung und anwendungsverfahren dafür
MX2021002902A (es) Composicion farmaceutica para prevenir o tratar la enfermedad del higado graso no alcoholico, que contiene ligando gpr119 como principio activo.
SG179131A1 (en) Modified erythropoietin to which water-soluble long-chain molecule is added
CL2020002728A1 (es) Composiciones de ácidos grasos poliinsaturados enriquecidos con dha
MX2011007222A (es) Composicion nutricional para infantes.
MX2023003147A (es) Mezclas de polisorbato que tienen distribucion de esteres de acidos grasos modificados.
CO2021000418A2 (es) Composiciones de ácidos grasos poliinsaturados enriquecidos con ala
AR122837A1 (es) Composiciones de ácidos grasos poliinsaturados enriquecidos con dha
WO2016008401A8 (zh) 一种含多西他赛的药物组合物
AR123578A1 (es) Mezclas de polisorbato que tienen distribución de ésteres de ácidos grasos modificados
CO2021000431A2 (es) Composiciones de ácidos grasos poliinsaturados enriquecidos con dha
PE20211482A1 (es) Composiciones de acidos grasos poliinsaturados enriquecidos con dha
MX2020013988A (es) Composiciones de acidos grasos poliinsaturados enriquecidos con dha.
PH12014502817A1 (en) Compounds from the fruits of acrocomia crispa and acrocomia aculeata for use against oxidative stress and inflammation
EA202092556A1 (ru) Композиции полиненасыщенных жирных кислот, обогащенные дгк